Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-058-7 | CAS number: 102-82-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
The LD50 for acute oral toxicity is 420 mg/kg bw (RL 2, rat). The acute dermal toxicity is reported with a LD50 of 195 mg/kg bw (RL 2, rabbit) as well as the toxicity via inhalation is characterised by a LC50 of 500 mg/m³ (RL 1, rat).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1974
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Reason / purpose for cross-reference:
- reference to same study
- Principles of method if other than guideline:
- Method: acute oral toxicity test
Screening acc. to Smyth et al., 1962 (animals non-fasted, no necropsy is reported) - GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: in-house breeding
- Age at study initiation: 4 to 5 weeks
- Weight at study initiation: 90 to 120 g
- Fasting period before study: no
- Diet: Rockland rat diet - Route of administration:
- oral: gavage
- Vehicle:
- other: Test substance probably applied in dilution, no data
- Doses:
- 4 doses in a logarithmic series (factor 2) (acc. to Smyth et al. 1962)
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 420 mg/kg bw
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- Single application of a range of doses of the test item to male Wistar rats resulted in a LD50 = 420 mg/kg bw.
- Executive summary:
Male Wistar rats (5 rats/sex/dose) were subjected to test acute oral toxicity. The test item (purity not mentioned) was administered by gavage to non-fasted animals in 4 different dose levels (logarithmic series) and were observed for further 14 days. The results obtained led to a LD50 = 420 mg/kg bw (Carpenter et al., 1974).
This published acute oral toxcicity study is, together with methodological details given in other publications of the group, performed well and basic data are given, thus the study can be juged reliable with restrictions (RL 2).
Reference
LD50 value is given as 0.54 ml/kg bw (conversion to mg/kg bw was done using the density d= 0.78 g/ccm). Fiducial range values (+/- 1.96 S.D.) were from about 280 - 610 mg/kg bw.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 420 mg/kg bw
- Quality of whole database:
- comprehensive database, many studies of limited reliability due to insufficient documentation, but overall comparable results
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 7 MAR 1986 to 7 MAY 1986
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- Principles of method if other than guideline:
- Method:
acute inhalation toxicity - GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK Ltd.
- Females (if applicable) nulliparous and non-pregnant: no data
- Age at study initiation: no data
- Weight at study initiation: ca. 200 g
- Fasting period before study: no
- Housing: 5 per sex per cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-24
- Humidity (%): 43-49
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: air
- Details on inhalation exposure:
- TEST ATMOSPHERE
- Brief description of analytical method used:
Sampling: 5 samples were withdrawn through an acetone-containing absorption trap.
Analysis: GC-FID analysis - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- Test concentrations (analytical): 0.35, 0.51, 0.73, and 2.27 mg/l (45.5, 66, 95, and 295 ppm)
Test concentrations (nominal): 0.46, 0.77, 1.02, 4.93 mg/l ( 60, 100, 133, 640 ppm) - No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: continuously during exposure, at least twice daily during the observation period
- Frequency of weighing: daily
- Necropsy of survivors performed: yes - Statistics:
- LC50 was calculated by the log probit method of Miller and Tainter.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 0.5 mg/L air
- Exp. duration:
- 4 h
- Mortality:
- see table
- Clinical signs:
- other: - abnormal breathing, restlessness, signs of irritation, closure of eyelids, excessive salivation, whole-body tremor, clonic convulsions, death - No symptoms were observed any more in surviving animals after 4 days.
- Gross pathology:
- - In deceased animals: hyperemic congestion of the lung.
- Surviving animals: no particular findings. - Interpretation of results:
- Category 1 based on GHS criteria
- Conclusions:
- Acute inhalation toxicity was tested for the test item (Tri-n-butylamine). Inhalation of 0.51 mg/L of test substance (tributylamin) vapour for 4 hours resulted in the death of 4 out of 5 male and 2 out of 5 female rats, resulting in a LC50 = 0.5 mg/L air.
- Executive summary:
Male and female rats (5 rats/sex/dose) were subjected to test acute inhalation toxicity. The animals were exposed (whole body) to vapour at analytical dose levels of 0.35, 0.51, 0.73, and 2.27 mg/L test item (purity 98.5%) for 4 h and were observed for further 14 days.
The animals showed abnormal breathing, restlessness, signs of irritation, closed eyelids, excessive salivation, whole body tremor and clonic convulsions, yet no symptoms were observed any more in surviving animals after 4 days. At a concentration of 0.51 mg/L air 4 out of 5 male and 2 out of 5 female rats died within 3 to 24 h.
The results obtained thus led to a LC50 = 0.5 mg/L air (Pennwalt Corp./HRC, 1987).
This acute inhalation study is performed comparable to guideline studys (OECD TG 403), thus it can be juged reliable (RL 1).
Reference
MORTALITY
male female
====================================
0 mg/l 0/5 0/5
0.35 mg/l 0/5 0/5
0.51 mg/l 4/5 2/5 (within 3 - 24 h)
0.73 mg/l 5/5 5/5 (within 2.5 - 4 h)
2.27 mg/l 5/5 5/5 (within 1 h)
====================================
LC50 = 0.5 mg/l (66 ppm)
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 500 mg/m³ air
- Quality of whole database:
- comprehensive database, many studies of limited reliability due to insufficient documentation, but overall comparable results
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1974
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Reason / purpose for cross-reference:
- reference to same study
- Principles of method if other than guideline:
- Method: acute dermal toxicity
Screening acc. to Smyth et al., 1962 and Smyth et al., 1954. - GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 2.5 to 3.5 kg - Type of coverage:
- occlusive
- Vehicle:
- not specified
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 1/10 of the body surface
- Type of wrap if used: plastic film - Duration of exposure:
- 24 h
- Doses:
- not stated
- No. of animals per sex per dose:
- 4
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 195 mg/kg bw
- Interpretation of results:
- Category 2 based on GHS criteria
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Testing for acute dermal toxicity led to a LD50 = 195 mg test item (Tributylamin) per kg bw. Due to this value the results were interpreted.
- Executive summary:
Male white New Zealand rabbits (4 animals/dose) were subjected to test acute dermal toxicity. The test item (purity not stated) was applied onto 1/10 of the body surface for 24 h under occlusive conditions. The effects were observed for further 14 days.
This single application of the test item to male New Zealand rabbits resulted in a LD50 = 195 mg/kg bw (Carpenter et al., 1974).
This acute dermal toxcicity study is performed well and basic data are given, thus the study can be juged reliable with restrictions (RL 2).
Reference
LD50 value is given as 0.25 ml/kg bw (conversion to mg/kg bw was done using the density d= 0.78 g/ccm). Fiducial range values (+/- 1.96 S.D.) were from about 120 - 316 mg/kg bw.
No further data e.g. on clinical signs or body weight were recorded.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 195 mg/kg bw
- Quality of whole database:
- sufficient data available for evaluation
Additional information
In a published study male Wistar rats (5 rats/sex/dose) were subjected to test acute oral toxicity. The test item (purity not mentioned) was administered by gavage to non-fasted animals in 4 different dose levels (logarithmic series) and were observed for further 14 days. The results obtained led to a LD50 = 420 mg/kg bw (Carpenter et al., 1974).
This reliable study was selected as key study. Another reliable experimental study performed (RL 2; according to OECD 401, but with deviations) in rats result in a slightly higher LD50 of 780 mg/kg bw, thus supporting previous findings (BASF, 1960). Several studies and published data of lower reliability (RL 3 und RL 4), which were conducted in rats, mice, rabbits, guinea pigs and cats confirmed the reported LD50 values in principle (Sidorin et al., 1984; Ciugudeanu et al., 1985; Din Min, 1977; BASF, 1959).
Male white New Zealand rabbits (4 animals/dose) were subjected to test acute dermal toxicity. The test item was applied onto 1/10 of the body surface for 24 h under occlusive conditions. The effects were observed for further 14 days.
This single application of the test item to male New Zealand rabbits resulted in a LD50 = 195 mg/kg bw (Carpenter et al., 1974).
This study was selected as key study for acute dermal toxicity due to the conservative LD50 value reported. Other reliable sources found a LD50 > 2000 mg/kg bw for the test item, but in another species (rat; BASF, 1981). A tail immersion assay (low reliability, RL 3) revealed a LT50 = 23 min in rats or mice (Sidorin et al., 1984).
Male and female rats (5 rats/sex/dose) were subjected to test acute inhalation toxicity. The animals were exposed (whole body) to vapour at analytical dose levels of 0.35, 0.51, 0.73, and 2.27 mg/L test item (purity 98.5%) for 4 h and were observed for further 14 days.
The animals showed abnormal breathing, restlessness, signs of irritation, closed eyelids, excessive salivation, whole body tremor and clonic convulsions, yet no symptoms were observed any more in surviving animals after 4 days. At a concentration of 0.51 mg/L air 4 out of 5 male and 2 out of 5 female rats died within 3 to 24 h. The results obtained thus led to a LC50 = 0.5 mg/L air (Pennwalt Corp./HRC, 1987).
This reliable study was selected as key study.
Another reliable source reported a similar LC50 of 690 mg/m³ air (BASF, 1983, RL 2). Additional supporting findings in studies of lower reliability are given as LC50 = 580 mg/m³ air (rat; Carpenter et al., 1974), LT0 = 50 min (rat, Carpenter et al., 1974), EC0 = 126 mg/m³ air (only 2 h exposure, in rats or mice; Sidorin et al., 1984), LC50 = 1000 mg/m³ (rat; Taminco file Bioserach(1976)), LC50 = 18000 mg/m³ (Arkema, 1976; 1 h, rat) or the results reported on short term risk inhalation tests (BASF, 1960).
Other routes of application examined gave the following results. Reports of low reliability present a LD50 = 107 mg/kg bw (intra peritoneal, in rats or mice; Sidorin et al., 1984) as well as a LDLo in the range of 310 - 390 mg/kg bw and a LD100 of 780 mg/kg bw (subcutaneous, rat; Hanzlik, 1923).
Justification for classification or non-classification
Based on the requirements of Regulation (EC) No 1272/2008 and an oral LD50 of 420 mg/kg bw in experimental animals tributylamine should be classified as acutely oral toxic category IV.
Based on the available data, which indicate the potential of acute dermal toxicity (LD50 of 195 mg/kg bw) tributylamine should be classified as acutely dermal toxic category II.
The given value of LC50 = 500 mg/m³ air results in a classification for acute toxicity via inhalation into toxicity category I according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.